Suppr超能文献

在 COVID-19 患者人群中,与 CD8+ T 细胞库中非结构表位丰度相关的等位基因减少。

allele diminishing in COVID-19 patients population associated with non-structural epitope abundance in CD8+ T-cell repertoire.

机构信息

Faculty of Biology and Biotechnology, HSE University, Moscow, Russia.

Institute of Molecular Biology, The National Academy of Sciences of the Republic of Armenia, Yerevan, Armenia.

出版信息

PeerJ. 2023 Jan 18;11:e14707. doi: 10.7717/peerj.14707. eCollection 2023.

Abstract

In mid-2021, the SARS-CoV-2 Delta variant caused the third wave of the COVID-19 pandemic in several countries worldwide. The pivotal studies were aimed at studying changes in the efficiency of neutralizing antibodies to the spike protein. However, much less attention was paid to the T-cell response and the presentation of virus peptides by MHC-I molecules. In this study, we compared the features of the HLA-I genotype in symptomatic patients with COVID-19 in the first and third waves of the pandemic. As a result, we could identify the diminishing of carriers of the allele in the third wave and demonstrate the unique properties of this allele. Thus, HLA-A*01:01-binding immunoprevalent epitopes are mostly derived from ORF1ab. A set of epitopes from ORF1ab was tested, and their high immunogenicity was confirmed. Moreover, analysis of the results of single-cell phenotyping of T-cells in recovered patients showed that the predominant phenotype in carriers is central memory T-cells. The predominance of T-lymphocytes of this phenotype may contribute to forming long-term T-cell immunity in carriers of this allele. Our results can be the basis for highly effective vaccines based on ORF1ab peptides.

摘要

2021 年年中,SARS-CoV-2 德尔塔变异株在全球多个国家引发了 COVID-19 大流行的第三波疫情。这些关键研究旨在研究针对刺突蛋白的中和抗体效率的变化。然而,人们对 T 细胞反应和 MHC-I 分子呈递病毒肽的关注要少得多。在这项研究中,我们比较了 COVID-19 大流行第一波和第三波中症状患者 HLA-I 基因型的特征。结果,我们可以识别出第三波中 等位基因携带者的减少,并证明了该等位基因的独特特性。因此,HLA-A*01:01 结合的免疫优势表位主要来自 ORF1ab。一组来自 ORF1ab 的表位进行了测试,并证实了它们具有较高的免疫原性。此外,对恢复期患者 T 细胞的单细胞表型分析结果表明, 携带者的主要表型是中央记忆 T 细胞。这种表型的 T 淋巴细胞的优势可能有助于形成该等位基因携带者的长期 T 细胞免疫。我们的研究结果可以为基于 ORF1ab 肽的高效疫苗提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd14/9864130/58f8108baffa/peerj-11-14707-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验